Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
Flexion Therapeutics (Nasdaq:FLXN) announced that CEO Michael Clayman will participate in a fireside chat at the 29th Annual Credit Suisse Virtual Healthcare Conference.
The event is set for November 11, 2020, starting at 8:45 a.m. ET. Investors can access the live webcast through Flexion's website. Flexion Therapeutics specializes in developing novel therapies for musculoskeletal conditions, especially osteoarthritis.
- None.
- None.
BURLINGTON, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 29th Annual Credit Suisse Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 8:45 a.m. ET on Wednesday, November 11, 2020.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com
FAQ
When is Michael Clayman's fireside chat at the Credit Suisse Virtual Healthcare Conference?
How can I access the webcast of the Flexion Therapeutics presentation?
What is the focus of Flexion Therapeutics?
What is the stock symbol for Flexion Therapeutics?
Who is participating in the Credit Suisse Virtual Healthcare Conference?
